Locally Advanced Gastroesophageal Junction Adenocarcinoma
8 clinical trials · Condition
◉ Watch Locally Advanced Gastroesophageal Junction Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma (NCT04989985) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-09-01 |
| Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer (NCT04511039) | Roswell Park Cancer Institute | 2021-06-08 |
| Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer (NCT04522336) | M.D. Anderson Cancer Center | 2020-09-16 |
| Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors (NCT04007744) | Mayo Clinic | 2020-02-13 |
Track Locally Advanced Gastroesophageal Junction Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.